Exemestane twenty five mg administered at the time day by day was evaluated in a very randomized double-blind, multicenter, multinational comparative study and in two multicenter one-arm scientific tests of postmenopausal Females with advanced breast cancer who had illness progression just after remedy with tamoxifen for metastatic disorder or as a